List of insiders holdings for Lyell Immunopharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | ARCH Venture Partners IX LLC ARCH Venture Fund IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners IX L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 2025-02-14 16:55:23 | 36,597,716 0 | 36,597,716 | Form 13G |
| 2 | NELSEN ROBERT Director 10% Owner | 2024-06-17 16:41:47 | 130,000 36,412,716 | 36,542,716 | Form 4 |
| 3 | GLAXOSMITHKLINE PLC 10% Owner | 2022-02-10 16:51:33 | 30,253,189 0 | 30,253,189 | Form 13G |
| 4 | Bishop Hans Edgar Director | 2024-06-17 16:17:47 | 4,815,614 0 | 4,815,614 | Form 4 |
| 5 | Klausner Richard Director | 2025-05-19 18:50:18 | 3,097,834 843,365 | 3,941,199 | Form 4 |
| 6 | Homans Elizabeth Chief Executive Officer | 2022-03-18 16:07:26 | 1,479,500 0 | 1,479,500 | Form 4 |
| 7 | Seely Lynn President and CEO | 2025-03-18 18:59:18 | 712,500 0 | 712,500 | Form 4 |
| 8 | Albertson Tina M. Chief Medical Officer | 2023-02-28 18:19:25 | 704,049 0 | 704,049 | Form 4 |
| 9 | Lee Gary K. Chief Scientific Officer | 2025-02-26 19:27:55 | 682,946 0 | 682,946 | Form 4 |
| 10 | Hill Stephen J. Chief Operating Officer | 2025-02-26 19:31:23 | 679,149 0 | 679,149 | Form 4 |
| 11 | Lang Matthew Chief Business Officer | 2025-02-26 19:36:04 | 668,750 0 | 668,750 | Form 4 |
| 12 | FRIEDMAN CATHY Director | 2025-05-19 18:47:00 | 130,000 336,370 | 466,370 | Form 4 |
| 13 | Newton Charles W. Chief Financial Officer | 2025-03-18 19:01:35 | 172,725 200,000 | 372,725 | Form 4 |
| 14 | Ramachandra Sumant Director | 2025-05-19 18:41:48 | 130,000 200,000 | 330,000 | Form 4 |
| 15 | Turner Heather D Chief General Counsel | 2022-03-18 16:11:11 | 300,000 0 | 300,000 | Form 4 |
| 16 | Thompson Rahsaan Chief Legal Officer | 2023-02-28 18:15:29 | 245,000 0 | 245,000 | Form 4 |
| 17 | BRAWLEY OTIS W Director | 2025-05-19 18:45:21 | 165,640 0 | 165,640 | Form 4 |
| 18 | NABEL ELIZABETH G Director | 2025-05-19 18:43:39 | 130,000 0 | 130,000 | Form 4 |
| 19 | RIEFLIN WILLIAM JL Director | 2025-05-19 18:48:48 | 130,000 0 | 130,000 | Form 4 |
| 20 | Meltz Mark A General Counsel | 2025-06-11 17:47:11 | 100,000 0 | 100,000 | Form 4 |
| 21 | Shook David Chief Medical Officer | 2025-06-11 17:45:48 | 65,650 0 | 65,650 | Form 4 |
| 22 | Bachleda Mark Director | 2025-06-11 17:48:27 | 13,000 0 | 13,000 | Form 4 |